Back to search

McMaster University

Leveraging Public Exome Sequencing Data to Find Rare Causal Variants in Type 2 Diabetes

Abstract

dc:description.abstract

Background: Type 2 Diabetes (T2D) is growing in prevalence worldwide over the last century. T2D incidence is linked to numerous complications, increased risk of heart disease, and oncology outcomes. This highlights the importance of preventive measures for T2D, wherein genetic predisposition can serve as an early warning sign. The role of rare variants (RVs) in T2D pathogenesis has not been adequately explored due to study size limitations, therefore we hypothesized that new associations could be found using publicly available data repositories. Methods: Significant RV gene burden for T2D risk was discovered using exome sequences obtained from the United Kingdom Biobank (UKB) (n=162,215), then tested for replication in the Korean Association Resource project (n=973), the Metabolic Syndrome in Men Study (n=969), the San Antonio Mexican American Family Studies (n=309), and a pooled meta-analysis of the latter three cohorts. RV gene burden was reassessed in secondary analyses using T2D cases from each cohort and summary level data from the Genome Aggregation Database (GnomAD) (n=125,748). Results: UKB exome wide significant associations were found in GCK (OR=2.44, p=8.91×10-11) and PAM (OR=1.32, p=1.39×10-6), and suggestive associations (p<0.001) were found in 33 additional genes. Replication was limited in KARE, METSIM, SAMAFS and in the secondary analyses with GnomAD because of limited sample sizes and miscalibration with the external control, respectively. Follow-up analyses include exploration of RV gene burden in additional diabetes subtypes, evaluation of clinical features between RV carriers and non-carriers, comparing the ability to predict T2D with rare variant, polygenic, and phenotypic risk scores. Methodological improvements include the incorporation of robust analytic tools and increasing access to a greater diversity and number of samples. Conclusion: Publicly available exome sequencing data has identified genes where RV burden affects T2D pathogenesis and risk. The study of rare genetic variation in diabetes is just beginning.

Degree

thesis:*
Department dc:contributor.department
Health Sciences
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Feiner, James
Advisor dc:contributor.advisor
  • Paré, Guillaume

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Feiner, James. Leveraging Public Exome Sequencing Data to Find Rare Causal Variants in Type 2 Diabetes. 2021. http://hdl.handle.net/11375/27220